Few words in cancer care carry as much emotional weight as “recurrence.” For many patients, the fear of cancer coming back lingers long after treatment ends. When recurrence is suspected or confirmed, pathology once again becomes central to answering the…
Clinical trials are often described as the engine that drives medical progress. For many patients, they also represent access to cutting-edge therapies that may not yet be widely available. Yet one of the most misunderstood aspects of clinical trial participation…
If you’ve ever opened a cancer pathology report and felt overwhelmed by unfamiliar terms, you are not alone. Words like “biomarkers,” “mutations,” “expression,” and “amplification” can feel abstract, technical, and intimidating. Yet these terms increasingly guide some of the most…
